September 29, 2026- Supplying non-acute healthcare facilities presents a unique set of challenges. In a recent podcast with The Journal of Healthcare Contracting, Travis Miller, Vice President of Supply Chain Management Operations at Advocate Health (Midwest region), discussed the logistical and strategic nuances involved in supporting a growing network of non-acute care … [Read more...]
U.S. ban on $1 billion worth of Canadian imports goes into effect
September 29, 2026- The United States went ahead early Tuesday with a decision to ban nearly $1 billion worth of Canadian imports, including alcoholic beverages, dairy products and motorcycles, according to AP News. The latest began this summer when the U.S. imposed 50% tariffs on about $20 billion worth of Canadian imports, charging that Canada discriminates against U.S. … [Read more...]
SAMHSA grants nearly $250 million for behavioral health services
September 29, 2026- The Substance Abuse and Mental Health Services Administration Sept. 25 announced that it awarded $247.9 million in grants for services expanding access to addiction treatment, mental health services, and recovery support across the U.S. SAMHSA said the funds will support mental health services in schools, trauma treatment for children and families, efforts … [Read more...]
Teleflex Arrowg+ard™ technology demonstrates reduced CLABSI risk
September 29, 2026- Teleflex Incorporated announced the publication of its latest peer-reviewed study in the American Journal of Infection Control demonstrating that Central Venous Catheters (CVCs) protected with Arrowg+ard™ Technology were associated with a statistically significant 70% lower hazard of central line-associated bloodstream infections (CLABSIs) compared with … [Read more...]
Cepheid receives FDA Clearance for Xpert® Respiratory Panel
September 29, 2026- Cepheid announced that it has received FDA clearance for the Xpert Respiratory Panel, a multiplex PCR test designed to detect 13 common viral and bacterial respiratory pathogens from a single nasopharyngeal swab sample. The test is intended to aid in the diagnosis of individuals suspected of having respiratory tract infection with clinical signs and symptoms … [Read more...]
University of Utah Health and Intermountain Health Primary Children’s expand pediatric care
September 28, 2026- University of Utah Health and Intermountain Health Primary Children’s Hospital are expanding specialized care, research, and clinical expertise for children facing pediatric pulmonary hypertension and complex cardiac conditions across the Mountain West. To address the critical regional need for specialized care, this expansion includes the establishment … [Read more...]
FDA issues draft guidance on robotically-assisted surgical devices
September 28, 2026- The Food and Drug Administration released draft guidance Sept. 24 that includes recommendations on non-clinical testing, clinical data and labeling for premarket submissions of certain robotically-assisted surgical devices. RASDs are teleoperated systems that assist qualified practitioners with precise positioning and control of one or more surgical … [Read more...]
Respiratory Season Rhythms
September 28, 2026- Nearly six years have passed since the pandemic first emerged, and disease trends for respiratory syncytial virus (RSV), COVID-19 and influenza have varied considerably each respiratory season since. In most regions of the U.S., RSV season typically starts during the fall and peaks in the winter, according to the Centers for Disease Control and Prevention … [Read more...]
U.S. and China agree to tariff cuts on $60 billion of goods
September 28, 2026- China and the U.S. have agreed to cut tariffs imposed on $60 billion worth of goods imported from each other, on products ranging from U.S. corn to cosmetics, and Chinese household appliances to toys, according to NBC News. The more favorable tariff treatment followed recommendations from the US-China Board of Trade and would improve market access for about … [Read more...]
Abbott technology linked to lower risk of death, heart complications for people with Type 2 diabetes
September 28, 2026- Abbott announced new data showing that the use of continuous glucose monitoring (CGM), including Libre technology, was associated with a lower risk of death and cardiovascular complications among adults with Type 2 diabetes using basal insulin therapy. In this large, real-world study, CGM use was linked to a 45% lower risk of death at 12 months and a 36% … [Read more...]









